345
Views
24
CrossRef citations to date
0
Altmetric
Research Article

In Vitro Assessment of Acyclovir Permeation Across Cell Monolayers in the Presence of Absorption Enhancers

, , , , &
Pages 279-288 | Published online: 25 Sep 2008

REFERENCES

  • Anderberg E. K., Artursson P. Epithelial transport of drugs in cell culture VIII. Effect of sodium dodecyl sulphate on cell membranes and tight junction permeability in human intestinal epithelial (Caco-2) cells. J. Pharm. Sci. 1993; 82: 392–398
  • Artursson P., Lindmark T., Davis S. S., Ilium L. Effect of chitosanon the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm. Res. 1994; 11: 1358–1361
  • Aungst B. J. Optimising oral bioavailability of pharmaceutical leads. AAPS Newsmagazine 2006; 9: 3
  • Balda M. S., Whitney J. A., Flores C., Gonzalez S., Cereijido M., Matter K. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J.Cell Biol. 1996; 134: 1031–1049
  • Bernkop-Schnurch A. Chitosan and its derivatives: Potential excipients for per oral peptide delivery systems. Int. J. Pharm. 2000; 194: 1–13
  • Canfield P. E., Geerdes A. M., Molitoris B. A. Effect of reversible ATP depletion on tight junction integrity in LLC-PK1 cells. Am. J. Physiol. 1991; 261: 1038–1045
  • De Clercq E. Antivirals for the treatment of herpesvirus infections. J. Antimicrob. Chemother. 1993; 32: 121–132
  • Dodane V., Khan M. A., Merwin J. R. Effect of chitosan on epithelial permeability and structure. Int. J. Pharm. 1999; 182: 21–32
  • Eckelman W. C. Radiolabeling with technetium-99m to study high-capacity and low capacity biochemical systems. Eur. J. Nucl. Med. 1995; 22: 249–263
  • Elion G. B., Furman P. A., Fyfe J. A., de Miranda P., Beauchamp L., Schaeffer H. J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc. Natl. Acad. Sci. U.S.A. 1977; 74: 5716–5720
  • Freshney R. I. Culture of animal cells: A manual of basic technique. Wiley, New York 1987
  • Furuse M., Fujita K., Hiiragi T., Fujimoto K., Tsukita S. Claudin-1 and -2: Novel integral membrane proteins localizing at tight junctions with no sequence similarity to occluding. J. Cell Biol. 1998; 141: 1539–1550
  • Furuse M., Hirase T., Itoh M., Nagafuchi A., Yonemura S., Tsukita S., et al. Occludin: A novel integral membrane protein localizing at tight junctions. J. Cell Biol. 1993; 123: 1777–1788
  • Hidalgo I. J. Assessing the absorption of new pharmaceuticals. Curr. Top. Med. Chem. 2001; 1: 385–401
  • Hovgaard L., Brondsted H. Drug delivery studies in Caco-2 monolayers. IV. Absorption enhancer effects of cyclodextrins. Pharm. Res. 1995; 12: 1328–1332
  • Irvine J. D., Takahashi L., Lockhart K., Cheong J., Tolan J. W., Selick H. E., et al. MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. J. Pharm. Sci. 1999; 88: 28–33
  • Jain S. K., Jain R. K., Chourasia M. K., Jain A. K., Chalasani K. B., Soni V., et al. Design and development of multivesicular liposomal depot delivery system for controlled systemic delivery of acyclovir sodium. AAPS Pharm. Sci., Tech. 2005; 6: E35–E41
  • Junginger H. E., Verhoef J. C. Macromolecules as safe penetration enhancers for hydrophilic drugs—A fiction?. Pharm. Sci. Technol. Today 1998; 1: 370–376
  • Kerec M., Bogataj M., Veranic P., Mrhar A. Permeability of pig urinary bladder wall: The effect of chitosan and the role of calcium. Eur. J. Pharm. Sci. 2005; 25: 113–121
  • Kotze A. F., Lueßen H. L., de Leeuw B. J., de Boer A. G., Verhoef J. C., Junginger H. E. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). J. Control. Release 1998; 51: 35–46
  • Kotze A. F., Thanou M. M., Lueβen H. L., de Leeuw B. J., de Boer A. G., Verhoef J. C., et al. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environment: In vitro evaluation in intestinal epithelial cells (Caco-2). J. Pharm. Sci. 1999; 88: 253–257
  • Kristl A., Tukker J. J. Negative correlation of n-octanol/water partition coefficient and transport of some guanine derivatives through rat jejunum in vitro. Pharm. Res. 1998; 15: 499–501
  • Lehr C. M., Bouwstra J. A., Schacht E. H., Junginger H. E. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 1992; 78: 43–48
  • Masson M., Loftsson T., Masson G., Stefansson E. cyclodextrins as permeation enhancers: Some theoretical evaluations and in vitro testing. J. Control. Release 1999; 59: 107–118
  • Miranda P. D., Blum M. R. Pharmacokinetics of acyclovir after intravenous and oral administration. J. Antimicrob. Chemother. 1983; 12: 29–37
  • Mishra A. K., Panwar P., Hosono M., Chuttani K., Mishra P., Sharma R. K., et al. A new bifunctional chelating agent conjugated with monoclonal antibody and labelled with technetium-99m for targeted scintigraphy: 6-(4-isothiocyanatobenzyl)-5, 7-dioxo-1, 11-(carboxymethyl)-1, 4, 8, 11-tetraazacyclotridecane. J. Drug Target. 2004; 12: 559–567
  • Mukherjee T., Squillantea E., Gillespieb M., Shao J. Transepithelial electrical resistance is not a reliable measurement of the Caco-2 monolayer integrity in Transwell. Drug Deliv. 2004; 11: 11–18
  • Noach A. B. J., Sakai M., Blom-Roosemalen M. C., de Jonge H. R., de Boer A. G., Breimer D. D. Effect of anisotonic conditions on the transport of hydrophilic model compounds across monolayers of human colonic cell lines. J. Pharmacol. Exp. Ther. 1994; 270: 1373–1380
  • Ranaldi G., Marigliano I., Vespignani I., Perozzi G., Sambuy Y. The effect of chitosan and other polycations on tight junction permeability in the human intestinal Caco-2 cell line. J. Nutr. Biochem. 2002; 13: 157–167
  • Schaeffer H. J., Beauchamp L., de Miranda P., Elion G. B., Bauer D. J., Collins P. 9-(2-Hydroxyethoxymethyl) guanine activity against viruses of the herpes group. Nature 1978; 272: 583–585
  • Schipper N. G. M., Olsson S., Hoogstraate J. A., deBoer A. G., Varum K. M., Artursson P. Chitosans as absorption enhancers for poorly absorbable drugs 2: Mechanism of absorption enhancement. Pharm. Res. 1997; 14: 923–929
  • Shah P. J, Jogani V., Bagchi T., Misra A. Role of Caco-2 cell monolayers in prediction of intestinal drug absorption. Biotechnol. Prog. 2006; 22: 186–198
  • Smith J., Wood E., Dornish M. Effect of chitosan on epithelial cell tight junctions. Pharm. Res. 2004; 21: 43–49
  • Stagni G., Ali M. E., Weng D. Pharmacokinetics of acyclovir in rabbit skin after IV-bolus, ointment, and iontophoretic administrations. Int. J. Pharm. 2004; 274: 201–211
  • Taub M. E., Kristensen L., Frokjaer S. Optimized conditions for MDCK cell permeability and turbidimetric solubility studies using compounds representative of BCS classes I-IV. Eur. J. Pharm. Sci. 2002; 15: 331–340
  • Thanou M. M., Verhoef J. C., Junginger H. E. Oral absorption and enhancement by chitosan and its derivatives. Adv. Drug Del. Rev. 2001; 52: 117–126
  • Tirumalasetty P., Eley J. G. Evaluation of dodecylmaltoside as a permeability enhancer for insulin using human carcinoma cells. J. Pharm. Sci. 2005; 94: 246–255
  • Tirumalasetty P., Eley J. G. Permeability enhancing effects of the alkylglycoside, octylglucoside, on insulin permeation across epithelial membrane in vitro. J. Pharm. Pharmaceut. Sci. 2006; 9: 32–39
  • Tolle-Sander S., Lentz K. A., Maeda D. Y., Coop A., Polli J. E. Increased acyclovir oral bioavailability via a bile acid conjugate. Mol. Pharm. 2004; 1: 40–48
  • Udata C., Patel J., Pal D., Hejchman E., Cushman M., Mitra A. K. Enhanced transport of a novel anti-HIV agent/cosalane and its congeners across human intestinal epithelial (Caco-2) cell monolayers. Int. J. Pharm. 2003; 250: 157–168
  • Vrueh R. L. A., de Smith P. L., Lee C. P. Transport of L-valine-acyclovir via the oligopeptide transporter in the human intestinal cell line, Caco-2. J. Pharmacol. Expt., Ther. 1998; 286: 1166–1170

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.